X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
- chromosome X -
| Symbol | GoldenPath (Mb) | Location | Description |
|---|---|---|---|
| ASMTL | 1482.032 | Xp22.3; Yp11.3 | acetylserotonin O-methyltransferase-like |
| ARSD | 2841.655 | Xp22.3 | arylsulfatase D |
| CXorf28 | 3199.861 | Xp22.33 | chromosome X open reading frame 28 |
| PRKX | 3532.411 | Xp22.3 | protein kinase, X-linked |
| HDHD1A | 6976.961 | Xp22.32 | haloacid dehalogenase-like hydrolase domain containing 1A |
| STS | 7147.472 | Xp22.32 | steroid sulfatase (microsomal), isozyme S |
| GPR143 | 9653.454 | Xp22.3 | G protein-coupled receptor 143 |
| CLCN4 | 10084.985 | Xp22.3 | chloride channel 4 |
| HCCS | 11039.373 | Xp22.3 | holocytochrome c synthase (cytochrome c heme-lyase) |
| ARHGAP6 | 11071.438 | Xp22.3 | Rho GTPase activating protein 6 |
| AMELX | 11221.454 | Xp22.31-p22.1 | amelogenin (amelogenesis imperfecta 1, X-linked) |
| TLR7 | 12795.123 | Xp22.3 | toll-like receptor 7 |
| TLR8 | 12834.679 | Xp22 | toll-like receptor 8 |
| TMSB4X | 12903.148 | Xq21.3-q22 | thymosin, beta 4, X-linked |
| EGFL6 | 13497.662 | Xp22 | EGF-like-domain, multiple 6 |
| LOC170082 | 13581.228 | Xp22.2 | TFS2-M domain-containing protein 1 |
| RAB9A | 13617.262 | Xp22.2 | RAB9A, member RAS oncogene family |
| FANCB | 14771.450 | Xp22.2 | Fanconi anemia, complementation group B |
| PIGA | 15247.501 | Xp22.1 | phosphatidylinositol glycan anchor biosynthesis, class A (paroxysmal nocturnal hemoglobinuria) |
| FIGF | 15273.640 | Xp22.31 | c-fos induced growth factor (vascular endothelial growth factor D) |
| FIM1 | 15273.640 | 6p23-p22.3 | Friend-murine leukemia virus integration site 1 homolog |
| FIM3 | 15273.640 | 3q27 | Friend-murine leukemia virus integration site 3 homolog |
| PIR | 15312.847 | Xp22.2 | pirin (iron-binding nuclear protein) |
| BMX | 15428.821 | Xp22.2 | BMX non-receptor tyrosine kinase |
| ACE2 | 15489.077 | Xp22 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
| GRPR | 16051.345 | Xp22.2-p22.13 | gastrin-releasing peptide receptor |
| CTPS2 | 16516.045 | Xp22 | CTP synthase II |
| S100G | 16578.202 | Xp22.2 | S100 calcium binding protein G |
| RBBP7 | 16772.698 | Xp22.2 | retinoblastoma binding protein 7 |
| REPS2 | 16874.735 | Xp22.2 | RALBP1 associated Eps domain containing 2 |
| SCML1 | 17665.513 | Xp22.2-p22.1 | sex comb on midleg-like 1 (Drosophila) |
| SCML2 | 18167.355 | Xp22 | sex comb on midleg-like 2 (Drosophila) |
| CDKL5 | 18353.646 | Xp22 | cyclin-dependent kinase-like 5 |
| PPEF1 | 18618.966 | Xp22.2-p22.1 | protein phosphatase, EF-hand calcium binding domain 1 |
| PHKA2 | 18820.800 | Xp22.2-p22.1 | phosphorylase kinase, alpha 2 (liver) |
| GPR64 | 18917.346 | Xp22.13 | G protein-coupled receptor 64 |
| PDHA1 | 19271.972 | Xp22.2-p22.1 | pyruvate dehydrogenase (lipoamide) alpha 1 |
| MAP3K15 | 19288.095 | Xp22.12 | mitogen-activated protein kinase kinase kinase 15 |
| SH3KBP1 | 19463.441 | Xp22.1-p21.3 | SH3-domain kinase binding protein 1 |
| EIF1AX | 20052.558 | Xp22.12 | eukaryotic translation initiation factor 1A, X-linked |
| RPS6KA3 | 20077.951 | Xp22.2-p22.1 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| DDX53 | 22928.008 | Xp22.11 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 |
| ACOT9 | 23631.699 | Xp22.11 | acyl-CoA thioesterase 9 |
| SAT1 | 23711.225 | Xp22.1 | spermidine/spermine N1-acetyltransferase 1 |
| PDK3 | 24393.475 | Xp22.11 | pyruvate dehydrogenase kinase, isozyme 3 |
| POLA1 | 24621.977 | Xp22.1-p21.3 | polymerase (DNA directed), alpha 1 |
| ARX | 24932.214 | Xp21 | aristaless related homeobox |
| MAGEB18 | 26066.384 | Xp21.3 | melanoma antigen family B, 18 |
| MAGEB6 | 26120.478 | Xp21.3 | melanoma antigen family B, 6 |
| MAGEB5 | 26145.340 | Xp21.3 | melanoma antigen family B, 5 |
| VENTXP1 | 26486.374 | Xp21.3 | VENT homeobox (Xenopus laevis) pseudogene 1 |
| MAGEB10 | 27736.046 | Xp21.3 | melanoma antigen family B, 10 |
| IL1RAPL1 | 28515.480 | Xp22.1-p21.3 | interleukin 1 receptor accessory protein-like 1 |
| MAGEB2 | 30143.601 | Xp21.3 | melanoma antigen family B, 2 |
| MAGEB3 | 30158.474 | Xp21.3 | melanoma antigen family B, 3 |
| MAGEB4 | 30170.090 | Xp21.3 | melanoma antigen family B, 4 |
| MAGEB1 | 30175.192 | Xp21.3 | melanoma antigen family B, 1 |
| NR0B1 | 30232.507 | Xp21.3-p21.2 | nuclear receptor subfamily 0, group B, member 1 |
| MAP3K7IP3 | 30755.481 | Xp21.2 | mitogen-activated protein kinase kinase kinase 7 interacting protein 3 |
| CXorf29 | 30762.661 | Xp21.2 | chromosome X open reading frame 29 |
| DMD | 31047.266 | Xp21.2 | dystrophin (muscular dystrophy, Duchenne and Becker types) |
| MAGEB16 | 35726.380 | Xp21.1 | melanoma antigen family B, 16 |
| BRAFPS2 | 35967.054 | Xq13.3 | similar to v-raf murine sarcoma viral oncogene homolog B1 pseudogene |
| CYBB | 37524.264 | Xp21.1 | cytochrome b-245, beta polypeptide (chronic granulomatous disease) |
| SRPX | 37893.537 | Xp21.1 | sushi-repeat-containing protein, X-linked |
| OTC | 38096.680 | Xp21.1 | ornithine carbamoyltransferase |
| TSPAN7 | 38305.683 | Xp11.4 | tetraspanin 7 |
| BCOR | 39816.124 | Xp21.2-p11.4 | BCL6 co-repressor |
| MED14 | 40393.739 | Xp11.4-p11.2 | mediator complex subunit 14 |
| DDX3X | 41077.595 | Xp11.3-p11.23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked |
| CASK | 41264.288 | Xp11.4 | calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
| PPP1R2P9 | 42521.562 | Xp11.4-p11.3 | protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9 |
| CXorf31 | 46631.799 | Xp11.3 | chromosome X open reading frame 31 |
| RBM10 | 46889.575 | Xp11.23 | RNA binding motif protein 10 |
| UBA1 | 46935.204 | Xp11.23 | ubiquitin-like modifier activating enzyme 1 |
| INE1 | 46949.269 | Xp11.4-p11.3 | inactivation escape 1 |
| PCTK1 | 46962.576 | Xp11.3-p11.23 | PCTAIRE protein kinase 1 |
| USP11 | 46977.258 | Xp11.23 | ubiquitin specific peptidase 11 |
| ARAFPS | 47305.451 | 7p12-q11.21 | v-raf murine sarcoma 3611 viral oncogene homolog pseudogene |
| ARAF | 47305.522 | Xp11.4-p11.2 | v-raf murine sarcoma 3611 viral oncogene homolog |
| TIMP1 | 47326.634 | Xp11.3-p11.23 | TIMP metallopeptidase inhibitor 1 |
| ELK1 | 47379.865 | Xp11.2 | ELK1, member of ETS oncogene family |
| ELK2P1 | 47379.864 | 14q32.3 | ELK2, member of ETS oncogene family, pseudogene 1 |
| UXT | 47396.140 | Xp11.23-p11.22 | ubiquitously-expressed transcript |
| SSX6 | 47852.032 | Xp11.2 | synovial sarcoma, X breakpoint 6 |
| SSX5 | 47930.600 | Xp11.23 | synovial sarcoma, X breakpoint 5 |
| SSX1 | 47999.741 | Xp11.23-p11.22 | synovial sarcoma, X breakpoint 1 |
| SSX10 | 48021.100 | Xp11.23 | synovial sarcoma, X breakpoint 10 |
| SSX9 | 48039.829 | Xp11.23 | synovial sarcoma, X breakpoint 9 |
| SSX3 | 48092.649 | Xp11.23 | synovial sarcoma, X breakpoint 3 |
| SSX4B | 48127.912 | Xp11.23 | synovial sarcoma, X breakpoint 4B |
| SSX4 | 48146.468 | Xp11.23 | synovial sarcoma, X breakpoint 4 |
| RBM3 | 48317.780 | Xp11.2 | RNA binding motif (RNP1, RRM) protein 3 |
| WAS | 48427.153 | Xp11.4-p11.21 | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) |
| SUV39H1 | 48440.075 | Xp11.23 | suppressor of variegation 3-9 homolog 1 (Drosophila) |
| GATA1 | 48529.906 | Xp11.23 | GATA binding protein 1 (globin transcription factor 1) |
| HDAC6 | 48545.431 | Xp11.23 | histone deacetylase 6 |
| ERAS | 48572.227 | Xp11.23 | ES cell expressed Ras |
| TIMM17B | 48635.676 | Xp11.23 | translocase of inner mitochondrial membrane 17 homolog B (yeast) |
| PIM2 | 48655.405 | Xp11.23 | pim-2 oncogene |
| GRIPAP1 | 48718.279 | Xp11 | GRIP1 associated protein 1 |
| TFE3 | 48771.186 | Xp11.22 | transcription factor binding to IGHM enhancer 3 |
| PRAF2 | 48815.764 | Xp11.23 | PRA1 domain family, member 2 |
| SYP | 48931.209 | Xp11.23-p11.22 | synaptophysin |
| FOXP3 | 48994.354 | Xp11.23 | forkhead box P3 |
| PPP1R3F | 49013.261 | Xp11.23 | protein phosphatase 1, regulatory (inhibitor) subunit 3F |
| GAGE4 | 49103.593 | Xp11.4-p11.2 | G antigen 4 |
| GAGE5 | 49103.601 | Xp11.4-p11.2 | G antigen 5 |
| GAGE8 | 49103.603 | Xp11.23 | G antigen 8 |
| GAGE12I | 49103.621 | Xp11.4-p11.2 | G antigen 12I |
| GAGE2A | 49113.115 | Xp11.23 | G antigen 2A |
| GAGE6 | 49221.982 | Xp11.4-p11.2 | G antigen 6 |
| GAGE3 | 49223.101 | Xp11.4-p11.2 | G antigen 3 |
| GAGE1 | 49250.567 | Xp11.4-p11.2 | G antigen 1 |
| PAGE1 | 49339.010 | Xp11.23 | P antigen family, member 1 (prostate associated) |
| PAGE4 | 49480.644 | Xp11.23 | P antigen family, member 4 (prostate associated) |
| PYY3 | 49807.454 | Xp11.22 | peptide YY, 3 |
| AKAP4 | 49842.175 | Xp11.2 | A kinase (PRKA) anchor protein 4 |
| CCNB3 | 50044.280 | Xp11 | cyclin B3 |
| BMP15 | 50670.524 | Xp11.2 | bone morphogenetic protein 15 |
| NUDT11 | 51249.603 | Xp11.22 | nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
| GSPT2 | 51503.267 | Xp11.23-p11.21 | G1 to S phase transition 2 |
| MAGED1 | 51653.438 | Xp11.23 | melanoma antigen family D, 1 |
| MAGED4B | 51944.659 | - | melanoma antigen family D, 4B |
| MAGED4 | 51944.748 | Xp11.22 | melanoma antigen family D, 4 |
| XAGE2 | 52397.079 | Xp11.22 | X antigen family, member 2 |
| XAGE1B | 52544.885 | Xp11.22 | X antigen family, member 1B |
| XAGE1D | 52557.781 | Xp11.22 | X antigen family, member 1D |
| SSX8 | 52668.903 | Xp11.23 | synovial sarcoma, X breakpoint 8 |
| SSX7 | 52689.836 | Xp11.23 | synovial sarcoma, X breakpoint 7 |
| SSX2 | 52797.033 | Xp11.23-p11.22 | synovial sarcoma, X breakpoint 2 |
| SSX2B | 52797.033 | Xp11.22 | synovial sarcoma, X breakpoint 2B |
| MIRN378 | 52841.909 | - | microRNA 378 |
| XAGE5 | 52857.953 | Xp11.22 | X antigen family, member 5 |
| XAGE3 | 52908.285 | Xp11.22-p11.21 | X antigen family, member 3 |
| TSPYL2 | 53128.287 | Xp11.2 | TSPY-like 2 |
| JARID1C | 53237.379 | Xp11.22-p11.21 | jumonji, AT rich interactive domain 1C |
| BZX | 53417.795 | Xq24-q27 | Bazex syndrome |
| SMC1A | 53417.797 | Xp11.22-p11.21 | structural maintenance of chromosomes 1A |
| HUWE1 | 53576.477 | Xp11.22 | HECT, UBA and WWE domain containing 1 |
| FGD1 | 54488.614 | Xp11.21 | FYVE, RhoGEF and PH domain containing 1 (faciogenital dysplasia) |
| MAGED2 | 54850.896 | Xp11.2 | melanoma antigen family D, 2 |
| TRO | 54963.974 | Xp11.22-p11.21 | trophinin |
| APEX2 | 55043.505 | Xp11.21 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
| PAGE5 | 55263.516 | Xp11.21 | P antigen family, member 5 (prostate associated) |
| MAGEH1 | 55495.263 | Xp11.21 | melanoma antigen family H, 1 |
| FOXR2 | 55666.558 | Xp11.21 | forkhead box R2 |
| KLF8 | 56275.632 | Xp11.21 | Kruppel-like factor 8 |
| ARHGEF9 | 62771.573 | Xq11.1 | Cdc42 guanine nucleotide exchange factor (GEF) 9 |
| FAM123B | 63321.722 | Xq11.1 | family with sequence similarity 123B |
| KIAA1166 | 64052.987 | Xq11.1 | KIAA1166 |
| MSN | 64804.236 | Xq11.2-q12 | moesin |
| EDA2R | 65732.208 | Xq12 | ectodysplasin A2 receptor |
| AR | 66705.408 | Xq11.2-q12 | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) |
| EFNB1 | 67965.556 | Xq12 | ephrin-B1 |
| EDA | 68752.636 | Xq12-q13.1 | ectodysplasin A |
| RAB41 | 69418.793 | Xq13.1 | RAB41, member RAS oncogene family |
| KIF4A | 69426.620 | Xq13.1 | kinesin family member 4A |
| DLG3 | 69581.449 | Xq13.1 | discs, large homolog 3 (neuroendocrine-dlg, Drosophila) |
| FOXO4 | 70232.751 | Xq13.1 | forkhead box O4 |
| IL2RG | 70243.984 | Xq13.1 | interleukin 2 receptor, gamma (severe combined immunodeficiency) |
| GJB1 | 70351.787 | Xq13.1 | gap junction protein, beta 1, 32kDa |
| NONO | 70420.192 | Xq13.1 | non-POU domain containing, octamer-binding |
| TAF1 | 70502.839 | Xq13.1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
| INGX | 70628.255 | Xq12 | inhibitor of growth family, X-linked, pseudogene |
| CXCR3 | 70752.492 | Xq13 | chemokine (C-X-C motif) receptor 3 |
| ERCC6L | 71341.232 | Xq13.1 | excision repair cross-complementing rodent repair deficiency, complementation group 6-like |
| CITED1 | 71438.227 | Xq13.1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
| HDAC8 | 71466.092 | Xq13 | histone deacetylase 8 |
| NAP1L6 | 72262.600 | Xq13.2 | nucleosome assembly protein 1-like 6 |
| CHIC1 | 72699.709 | Xq13-q21 | cysteine-rich hydrophobic domain 1 |
| XIST | 72959.886 | Xq13.2 | X (inactive)-specific transcript |
| RNF12 | 73726.777 | Xq13-q21 | ring finger protein 12 |
| MAGEE2 | 74919.548 | Xq13.3 | melanoma antigen family E, 2 |
| MAGEE1 | 75564.521 | Xq13.3 | melanoma antigen family E, 1 |
| FGF16 | 76596.303 | Xq13 | fibroblast growth factor 16 |
| ATRX | 76647.012 | Xq13.1-q21.1 | alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) |
| COX7B | 77041.617 | Xq21.1 | cytochrome c oxidase subunit VIIb |
| ATP7A | 77052.876 | Xq13.2-q13.3 | ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome) |
| PGK1 | 77246.425 | Xq13 | phosphoglycerate kinase 1 |
| CYSLTR1 | 77414.787 | Xq13.2-q21.1 | cysteinyl leukotriene receptor 1 |
| SEPT9 | 77414.787 | 17q25 | septin 9 |
| BRWD3 | 79818.339 | Xq21.1 | bromodomain and WD repeat domain containing 3 |
| RPS6KA6 | 83205.640 | Xq21 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
| hCG_1644608 | 83896.661 | Xq21.1 | SET translocation (myeloid leukemia-associated) pseudogene |
| CHM | 85002.842 | Xq21.2 | choroideremia (Rab escort protein 1) |
| DACH2 | 85290.281 | Xq21.3 | dachshund homolog 2 (Drosophila) |
| DIAPH2 | 95826.365 | Xq22 | diaphanous homolog 2 (Drosophila) |
| RPA4 | 96025.563 | Xq21.33 | replication protein A4, 34kDa |
| NOX1 | 99984.969 | Xq22 | NADPH oxidase 1 |
| TIMM8A | 100487.306 | Xq22.1 | translocase of inner mitochondrial membrane 8 homolog A (yeast) |
| BTK | 100491.098 | Xq21.33-q22 | Bruton agammaglobulinemia tyrosine kinase |
| RPL36A | 100532.604 | Xq22.1 | ribosomal protein L36a |
| ARMCX1 | 100692.170 | Xq21.33-q22.2 | armadillo repeat containing, X-linked 1 |
| ARMCX3 | 100764.776 | Xq21.33-q22.2 | armadillo repeat containing, X-linked 3 |
| ARMCX2 | 100796.926 | Xq21.33-q22.2 | armadillo repeat containing, X-linked 2 |
| TMSL8 | 101655.267 | Xq21.33-q22.3 | thymosin-like 8 |
| RAB40AL | 102078.856 | - | RAB40A, member RAS oncogene family-like |
| NXF3 | 102217.408 | Xq22-q23 | nuclear RNA export factor 3 |
| BEX2 | 102450.931 | Xq22 | brain expressed X-linked 2 |
| TCEAL7 | 102471.821 | Xq22.1 | transcription elongation factor A (SII)-like 7 |
| NGFRAP1 | 102517.924 | Xq22.2 | nerve growth factor receptor (TNFRSF16) associated protein 1 |
| RAB40A | 102641.338 | Xq22.1 | RAB40A, member RAS oncogene family |
| TCEAL4 | 102727.075 | Xq22.2 | transcription elongation factor A (SII)-like 4 |
| TCEAL1 | 102770.304 | Xq22.1 | transcription elongation factor A (SII)-like 1 |
| RAB9B | 102966.607 | Xq22.1-q22.3 | RAB9B, member RAS oncogene family |
| TEX13A | 104350.267 | Xq22.3 | testis expressed 13A |
| KCTD9L | 104536.840 | Xq22.3 | potassium channel tetramerisation domain containing 9-like |
| LOC203510 | 104953.192 | Xq23 | similar to high-mobility group box 3 |
| MUM1L1 | 105307.975 | Xq22.3 | melanoma associated antigen (mutated) 1-like 1 |
| RNF128 | 105856.550 | Xq22.3 | ring finger protein 128 |
| CLDN2 | 106050.290 | Xq22.3-q23 | claudin 2 |
| PRPS1 | 106758.415 | Xq21.32-q24 | phosphoribosyl pyrophosphate synthetase 1 |
| VSIG1 | 107174.856 | Xq22.3 | V-set and immunoglobulin domain containing 1 |
| PSMD10 | 107214.095 | Xq22.3 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 |
| ATG4A | 107221.590 | Xq22.1-q22.3 | ATG4 autophagy related 4 homolog A (S. cerevisiae) |
| COL4A6 | 107285.493 | Xq22 | collagen, type IV, alpha 6 |
| COL4A5 | 107569.810 | Xq22 | collagen, type IV, alpha 5 (Alport syndrome) |
| IRS4 | 107862.370 | Xq22.3 | insulin receptor substrate 4 |
| GUCY2F | 108502.791 | Xq22 | guanylate cyclase 2F, retinal |
| ACSL4 | 108771.222 | Xq22.3-q23 | acyl-CoA synthetase long-chain family member 4 |
| AMMECR1 | 109324.071 | Xq22.3 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region, gene 1 |
| TDGF3 | 109650.195 | Xq22.3 | teratocarcinoma-derived growth factor 3, pseudogene |
| PAK3 | 110226.256 | Xq22.3-q23 | p21 (CDKN1A)-activated kinase 3 |
| DCX | 110423.664 | Xq22.3-q23 | doublecortex; lissencephaly, X-linked (doublecortin) |
| AMOT | 111904.762 | Xq23 | angiomotin |
| IL13RA2 | 114144.796 | Xq13.1-q28 | interleukin 13 receptor, alpha 2 |
| LUZP4 | 114430.548 | Xq23 | leucine zipper protein 4 |
| AGTR2 | 115215.986 | Xq22-q23 | angiotensin II receptor, type 2 |
| SLC6A14 | 115481.818 | Xq23-q24 | solute carrier family 6 (amino acid transporter), member 14 |
| LONRF3 | 117992.741 | Xq24 | LON peptidase N-terminal domain and ring finger 3 |
| PGRMC1 | 118254.291 | Xq22-q24 | progesterone receptor membrane component 1 |
| SLC25A5 | 118486.433 | Xq24-q26 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
| UBE2A | 118592.527 | Xq24-q25 | ubiquitin-conjugating enzyme E2A (RAD6 homolog) |
| NKRF | 118606.335 | Xq24 | NF-kappaB repressing factor |
| SEPT6 | 118634.937 | Xq24 | septin 6 |
| NDUFA1 | 118889.762 | Xq24 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
| AKAP14 | 118913.964 | Xq24 | A kinase (PRKA) anchor protein 14 |
| ZBTB33 | 119268.635 | Xq23 | zinc finger and BTB domain containing 33 |
| LAMP2 | 119454.393 | Xq24 | lysosomal-associated membrane protein 2 |
| CUL4B | 119542.474 | Xq23 | cullin 4B |
| MCTS1 | 119621.863 | Xq22-q24 | malignant T cell amplified sequence 1 |
| CT47.13 | 119890.485 | Xq24 | cancer/testis CT47 family, member 13 |
| RP6-166C19.10 | 119895.376 | Xq24 | cancer/testis CT47 family, member 10 |
| CT47.7 | 119914.818 | Xq24 | cancer/testis CT47 family, member 7 |
| CT47.8 | 119914.818 | Xq24 | cancer/testis CT47 family, member 8 |
| RP6-166C19.2 | 119914.818 | Xq24 | cancer/testis CT47 family, member 2 |
| RP6-166C19.4 | 119914.818 | Xq24 | cancer/testis CT47 family, member 4 |
| RP6-166C19.5 | 119914.818 | Xq24 | cancer/testis CT47 family, member 5 |
| RP6-166C19.6 | 119919.701 | Xq24 | cancer/testis CT47 family, member 6 |
| RP6-166C19.11 | 119924.562 | Xq24 | cancer/testis CT47 family, member 11 |
| RP6-166C19.3 | 119924.562 | Xq24 | cancer/testis CT47 family, member 3 |
| RP6-166C19.1 | 119934.282 | Xq24 | cancer/testis CT47 family, member 1 |
| RP6-166C19.9 | 119939.141 | Xq24 | cancer/testis CT47 family, member 9 |
| GRIA3 | 122145.777 | Xq25-q26 | glutamate receptor, ionotrophic, AMPA 3 |
| XIAP | 122821.729 | Xq25 | baculoviral IAP repeat-containing 4 |
| SH2D1A | 123307.831 | Xq25-q26 | SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) |
| SMARCA1 | 128408.159 | Xq25 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
| OCRL | 128501.933 | Xq25-q26.1 | oculocerebrorenal syndrome of Lowe |
| APLN | 128607.007 | Xq25-q26.3 | apelin, AGTRL1 ligand |
| ZDHHC9 | 128766.596 | Xq26.1 | zinc finger, DHHC-type containing 9 |
| UTP14A | 128867.840 | Xq25 | UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) |
| BCORL1 | 128944.350 | Xq25-q26.1 | BCL6 co-repressor-like 1 |
| ELF4 | 129026.586 | Xq26 | E74-like factor 4 (ets domain transcription factor) |
| RAB33A | 129133.454 | Xq25 | RAB33A, member RAS oncogene family |
| ENOX2 | 129585.040 | Xq25-q26.2 | ecto-NOX disulfide-thiol exchanger 2 |
| RP6-213H19.1 | 130984.926 | Xq26.2 | serine/threonine protein kinase MST4 |
| RAP2C | 131164.735 | Xq25 | RAP2C, member of RAS oncogene family |
| GPC4 | 132262.730 | Xq26.1 | glypican 4 |
| GPC3 | 132497.444 | Xq26.1 | glypican 3 |
| HPRT1 | 133421.923 | Xq26.1 | hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) |
| PLAC1 | 133527.539 | Xq26 | placenta-specific 1 |
| DDX26B | 134482.250 | Xq26.3 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
| XX-FW88277B6.1 | 134674.851 | Xq26.3 | cancer/testis antigen CT45-1 |
| RP13-36C9.1 | 134693.880 | Xq26.3 | cancer/testis antigen CT45 |
| RP13-36C9.3 | 134711.154 | Xq26.3 | cancer/testis antigen CT45-3 |
| CT45-4 | 134756.364 | Xq26.3 | cancer/testis antigen CT45-4 |
| RP13-36C9.6 | 134773.631 | Xq26.3 | cancer/testis antigen CT45-5 |
| CT45-6 | 134790.882 | Xq26.3 | cancer/testis antigen CT45-6 |
| SAGE1 | 134803.451 | Xq26 | sarcoma antigen 1 |
| FHL1 | 135057.346 | Xq26 | four and a half LIM domains 1 |
| BRS3 | 135397.791 | Xq26-q28 | bombesin-like receptor 3 |
| CD40LG | 135558.002 | Xq26 | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) |
| ARHGEF6 | 135575.377 | Xq26 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
| RBMX | 135783.285 | Xq26.3 | RNA binding motif protein, X-linked |
| ZIC3 | 136476.012 | Xq26.2 | Zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) |
| FGF13 | 137541.402 | Xq26.3 | fibroblast growth factor 13 |
| MCF2 | 138491.596 | Xq27 | MCF.2 cell line derived transforming sequence |
| LOC286411 | 139619.597 | Xq27.1 | hypothetical protein LOC286411 |
| SPANXB2 | 139924.427 | Xq27.1 | SPANX family, member B2 |
| LDOC1 | 140097.607 | Xq27 | leucine zipper, down-regulated in cancer 1 |
| SPANXC | 140163.263 | Xq27.1 | SPANX family, member C |
| SPANXA1 | 140505.525 | Xq27.1 | sperm protein associated with the nucleus, X-linked, family member A1 |
| SPANXD | 140613.234 | Xq27.1 | SPANX family, member D |
| SPANXE | 140613.234 | Xq27.1 | SPANX family, member E |
| MAGEC3 | 140810.118 | Xq27.2 | melanoma antigen family C, 3 |
| MAGEC1 | 140819.346 | Xq26 | melanoma antigen family C, 1 |
| MAGEC2 | 141117.796 | Xq27 | melanoma antigen family C, 2 |
| UBE2NL | 142794.839 | Xq27.3 | ubiquitin-conjugating enzyme E2N-like |
| SPANXN1 | 144136.799 | Xq27 | SPANX family, member N1 |
| MAGEA11 | 148575.479 | Xq28 | melanoma antigen family A, 11 |
| MAGEA9 | 148671.402 | Xq28 | melanoma antigen family A, 9 |
| MAGEA8 | 148770.654 | Xq28 | melanoma antigen family A, 8 |
| MTM1 | 149487.727 | Xq28 | myotubularin 1 |
| ND4 | 149487.727 | - | NADH dehydrogenase, subunit 4 (complex I) |
| ND5 | 149487.727 | - | NADH dehydrogenase, subunit 5 (complex I) |
| CD99L2 | 149685.468 | Xq28 | CD99 molecule-like 2 |
| HMGB3 | 149902.421 | Xq28 | high-mobility group box 3 |
| MAGEA4 | 150836.053 | Xq28 | melanoma antigen family A, 4 |
| MAGEA5 | 151033.182 | Xq28 | melanoma antigen family A, 5 |
| MAGEA10 | 151053.565 | Xq28 | melanoma antigen family A, 10 |
| MAGEA7 | 151617.886 | Xq28 | melanoma antigen family A, 7, pseudogene |
| MAGEA6 | 151617.901 | Xq28 | melanoma antigen family A, 6 |
| MAGEA12 | 151649.952 | Xq28 | melanoma antigen family A, 12 |
| CSAG1 | 151653.884 | Xq28 | chondrosarcoma associated gene 1 |
| MAGEA2 | 151669.044 | Xq28 | melanoma antigen family A, 2 |
| MAGEA2B | 151669.059 | Xq28 | melanoma antigen family A, 2B |
| CSAG2 | 151678.390 | Xq28 | CSAG family, member 2 |
| MAGEA3 | 151685.309 | Xq28 | melanoma antigen family A, 3 |
| CETN2 | 151746.529 | Xq28 | centrin, EF-hand protein, 2 |
| TGCT1 | 151750.167 | Xq27 | testicular germ cell tumor susceptibility 1 |
| ZNF185 | 151833.653 | Xq28 | zinc finger protein 185 (LIM domain) |
| MAGEA1 | 152134.716 | Xq28 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) |
| TREX2 | 152363.373 | Xq28 | three prime repair exonuclease 2 |
| BGN | 152413.605 | Xq28 | biglycan |
| DUSP9 | 152561.182 | Xq28 | dual specificity phosphatase 9 |
| SSR4 | 152713.288 | Xq28 | signal sequence receptor, delta (translocon-associated protein delta) |
| L1CAM | 152780.581 | Xq28 | L1 cell adhesion molecule |
| LCAP | 152799.321 | Xq28 | lung carcinoma-associated protein |
| AVPR2 | 152823.564 | Xq28 | arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) |
| ARHGAP4 | 152826.025 | Xq28 | Rho GTPase activating protein 4 |
| ARD1A |